NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market Tuesday that its fourth-quarter revenues increased 364 percent year over year, driven by reagent sales from greater system placements.

The Carlsbad, Calif.-based molecular diagnostics firm had total revenues of $9.4 million for the three months ended Dec. 31, compared to $2 million for the fourth quarter of 2011. Its reagent sales were up more than 400 percent to $9.1 million from $1.8 million, while its instrument and other revenues climbed 39 percent to $312,000 from $224,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.